| Literature DB >> 36235292 |
Rawan H Hareeri1, Mohammed M Aldurdunji2, Hossam M Abdallah3,4, Ali A Alqarni3,5, Shaimaa G A Mohamed6, Gamal A Mohamed3, Sabrin R M Ibrahim7,8.
Abstract
Fungus continues to attract great attention as a promising pool of biometabolites. Aspergillus ochraceus Wilh (Aspergillaceae) has established its capacity to biosynthesize a myriad of metabolites belonging to different chemical classes, such as isocoumarins, pyrazines, sterols, indole alkaloids, diketopiperazines, polyketides, peptides, quinones, polyketides, and sesquiterpenoids, revealing various bioactivities that are antimicrobial, cytotoxic, antiviral, anti-inflammatory, insecticidal, and neuroprotective. Additionally, A. ochraceus produces a variety of enzymes that could have variable industrial and biotechnological applications. From 1965 until June 2022, 165 metabolites were reported from A. ochraceus isolated from different sources. In this review, the formerly separated metabolites from A. ochraceus, including their bioactivities and biosynthesis, in addition, the industrial and biotechnological potential of A. ochraceus are highlighted.Entities:
Keywords: Aspergillaceae; Aspergillus ochraceus; bioactivities; biosynthesis; enzymes; fungi; metabolites
Mesh:
Substances:
Year: 2022 PMID: 36235292 PMCID: PMC9572620 DOI: 10.3390/molecules27196759
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Isocoumarin derivatives (1–11) reported from A. ochraceus.
Figure 2Isocoumarin derivatives (12–24) reported from A. ochraceus.
Secondary metabolites reported from Aspergillus ochraceus (chemical class, molecular weight and formulae, fungal source, host, and place).
| Compound Name/Chemical Class | Mol. Wt. | Mol. Formula | Host (Part, Family)/Location | Ref. |
|---|---|---|---|---|
| Isocoumarin derivatives | ||||
| 3 | 178 | C10H10O3 | Wet maize meal | [ |
| - | - | Sea of Japan sediment | [ | |
| - | - | [ | ||
| - | - | [ | ||
| (3 | 194 | C10H10O4 | Cultured | [ |
| - | - | Rhizospheric soil of | [ | |
| - | - | Pacific Ocean, China | [ | |
| (3 | 194 | C10H10O4 | Rhizospheric soil of | [ |
| ( | 194 | C10H10O4 | Rhizospheric soil of | [ |
| ( | 255 | C10H9BrO3 | [ | |
| (±)-4,7-Dihydroxymellein ( | 210 | C10H10O5 | Pacific Ocean, China | [ |
| (3 | 210 | C10H10O5 | Deep-sea water, Northeastern Pacific, China | [ |
| 6-Methoxy-8-hydroxyisocoumarin-3-carboxylic acid ( | 236 | C11H8O6 | Cultured | [ |
| (±)-Botryoisocoumarin A ( | 208 | C11H12O4 | Rhizospheric soil of | [ |
| Diaporthin ( | 250 | C13H14O5 | Cultured | [ |
| Orthosporin ( | 236 | C12H12O5 | Cultured | [ |
| Ochratoxin α ( | 256 | C11H9ClO5 | Cultured | [ |
| Ochratoxin β ( | 222 | C11H10O5 | Cultured | [ |
| Ochratoxin A ( | 403 | C20H18ClNO6 | Wet maize meal | [ |
| - | - | [ | ||
| 4- | 419 | C20H18ClNO7 | Cultured | [ |
| 4- | 419 | C20H18ClNO7 | Cultured | [ |
| 10-Hydroxyochratoxin A ( | 419 | C20H18ClNO7 | Cultured | [ |
| Ochratoxin B ( | 369 | C20H19NO6 | Wet maize meal | [ |
| - | - | [ | ||
| Bromo-ochratoxin B ( | 447 | C20H18BrNO6 | Cultured | [ |
| 4- | 385 | C20H19NO7 | Cultured | [ |
| Ochratoxin C ( | 431 | C22H22ClNO6 | Wet maize meal | [ |
| HO-Proline-ochratoxin ( | 369 | C16H16ClNO7 | Cultured | [ |
| Serine-ochratoxin ( | 343 | C14H14ClNO7 | Cultured | [ |
| Lysine-ochratoxin ( | 384 | C17H21ClN2O6 | Cultured | [ |
| Pyrazine derivatives | ||||
| Flavacol ( | 208 | C12H20N2O | Moldy rice | [ |
| - | - | Laboratory infected soil | [ | |
| - | - | [ | ||
| 6-(2-Hydroxy-2-methylpropyl)-3-isobutylpyrazin-2-ol ( | 224 | C12H20N2O2 | Moldy rice | [ |
| Neoaspergillc acid ( | 224 | C12H20N2O2 | Moldy rice | [ |
| - | - | [ | ||
| Neohydroxyaspergillc acid ( | 240 | C12H20N2O3 | Moldy rice | [ |
| - | - | [ | ||
| β-Hydroxyneoaspergillic acid ( | 240 | C12H20N2O3 | Moldy rice | [ |
| - | - | [ | ||
| Deoxy-β-hydroxyneoaspergillic acid ( | 224 | C12H20N2O2 | Moldy rice | [ |
| - | - | [ | ||
| Ochramide A ( | 224 | C12H20N2O2 | [ | |
| Ochramide B ( | 238 | C13H22N2O2 | [ | |
| Ochramide C ( | 254 | C13H22N2O3 | [ | |
| Ochramide D ( | 238 | C12H18N2O3 | [ | |
| 3-Isobutyl-6-(1-hydroxy-2-methylpropyl)-2(1 | 224 | C12H20N2O2 | [ | |
| Ferrineoaspergillin ( | 725 | C36H57FeN6O6 | Moldy rice | [ |
| Ochralate A ( | 786 | C39H63AlN6O9 | [ | |
| Aluminiumneoaspergillin ( | 744 | C36H57AlN6O9 | South China Sea | [ |
| Diketopiperazines | ||||
| Waspergillamide B ( | 450 | C20H26N4O8 | [ | |
| Epiamauromine ( | 508 | C32H36N4O2 | Cultured | [ |
| N-Methylepiamauromine ( | 522 | C33H38N4O2 | Cultured | [ |
| Cycloechinulin ( | 351 | C20H21N3O3 | Cultured | [ |
| CJ-17,665 = Avrainvillamide ( | 445 | C26H27N3O4 | Soil, Venezuela | [ |
| Stephacidin A ( | 431 | C26H29N3O3 | Light brown clay, Sirsaganj, Uttar | [ |
| - | - | Laboratory infected soil | [ | |
| - | - | Soil, China | [ | |
| - | - | [ | ||
| Stephacidin B ( | 890 | C52H54N6O8 | Light brown clay, Sirsaganj, Uttar | [ |
| Speramide A ( | 447 | C26H29N3O4 | Freshwater, Fuxian Lake, China | [ |
| Speramide B ( | 465 | C26H31N3O5 | Freshwater, Fuxian Lake, China | [ |
| Asperochramide A ( | 451 | C26H33N3O4 | Soil, China | [ |
| Asperochramide B ( | 451 | C26H33N3O4 | Soil, China | [ |
| Asperochramide C ( | 397 | C21H23N3O5 | Soil, China | [ |
| Asperochramide D ( | 315 | C16H17N3O4 | Soil, China | [ |
| Notoamide A ( | 463 | C26H29N3O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Notoamide B ( | 447 | C26H29N3O4 | [ | |
| - | - | Soil, China | [ | |
| Notoamide C ( | 449 | C26H31N3O4 | Soil, China | [ |
| Notoamide F ( | 461 | C27H31N3O4 | Marine Culture, Pacific Ocean, China | [ |
| Notoamide I ( | 445 | C26H27N3O4 | Deep-sea water, Northeastern Pacific, China | [ |
| Notoamide M ( | 465 | C26H31N3O5 | Soil, China | [ |
| - | - | Deep-sea water, Northeastern Pacific, China | [ | |
| Notoamide X ( | 461 | C26H27N3O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Sclerotiamide ( | 463 | C26H29N3O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Taichunamide D ( | 509 | C27H31N3O5S | Soil, China | [ |
| Versicolamide B ( | 447 | C26H29N3O4 | Marine Culture, Pacific Ocean, China | [ |
| Brevianamide F ( | 283 | C16H17N3O2 | Soil, China | [ |
| Benzodiazepines | ||||
| (11a | 246 | C13H14N2O3 | [ | |
| Circumdatin A ( | 363 | C20H17N3O4 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | [ | ||
| Circumdatin B ( | 393 | C21H19N3O5 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | [ | ||
| Circumdatin C ( | 307 | C17H13N3O3 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | Sea of Japan sediment | [ | |
| - | - | [ | ||
| 2-Hydroxycircumdatin C ( | 323 | C17H13N3O4 | [ | |
| - | - | [ | ||
| Circumdatin D ( | 393 | C21H19N3O5 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | Laboratory infected soil | [ | |
| - | - | [ | ||
| Circumdatin E ( | 363 | C20H17N3O4 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | Laboratory infected soil | [ | |
| - | - | [ | ||
| Circumdatin F ( | 291 | C17H13N3O2 | Sterilized milo sorghum seeds buried in the soil for 1–4 months, Sevilleta National Wildlife Refuge, Socorro County, New Mexico, USA | [ |
| - | - | Sea of Japan sediment | [ | |
| - | - | [ | ||
| - | - | [ | ||
| Circumdatin G ( | 307 | C17H13N3O3 | Sea of Japan sediment | [ |
| - | - | [ | ||
| Circumdatin H ( | 347 | C20H17N3O3 | Laboratory infected soil | [ |
| - | - | [ | ||
| Circumdatin I ( | 323 | C17H13N3O4 | Cultured | [ |
| Circumdatin L ( | 307 | C17H13N3O3 | [ | |
| Circumdatin N ( | 307 | C17H13N3O3 | Marine Culture, Pacific Ocean, China | [ |
| Ochrazepine A ( | 507 | C26H25N3O8 | [ | |
| Ochrazepine B ( | 507 | C26H25N3O8 | [ | |
| Ochrazepine C ( | 507 | C26H25N3O8 | [ | |
| Ochrazepine D ( | 507 | C26H25N3O8 | [ | |
| Indole and other alkaloids | ||||
| Ochrindole A ( | 452 | C29H28N2O3 | Cultured | [ |
| Ochrindole B ( | 468 | C29H28N2O4 | Cultured | [ |
| Ochrindole C ( | 438 | C28H26N2O3 | Cultured | [ |
| Ochrindole D ( | 422 | C27H22N2O3 | Cultured | [ |
| Perlolyrine ( | 264 | C16H12N2O2 | Marine Culture, Pacific Ocean, China | [ |
| Ochracesol A ( | 205 | C11H11NO3 | Marine Culture, Pacific Ocean, China | [ |
| L-657,398 ( | 317 | C21H35NO | Cultured | [ |
| Cycloanthranilylproline ( | 230 | C13H14N2O2 | [ | |
| Peptides | ||||
| Aspochracin ( | 432 | C23H36N4O4 | Cultured | [ |
| Violaceotide A ( | 476 | C24H36N4O6 | [ | |
| Sesquiterpenoids | ||||
| 6β,9α-Dihydroxy-14- | 431 | C22H25NO8 | [ | |
| Insulicolide A ( | 431 | C22H25NO8 | [ | |
| 14-O-Acetylinsulicolide A ( | 475 | C23H25NO10 | [ | |
| 9-Deoxyinsulicolide A ( | 415 | C22H25NO7 | [ | |
| Insulicolide B ( | 415 | C22H25NO7 | [ | |
| Insulicolide C ( | 459 | C23H25NO9 | [ | |
| 6β,14-Dihydroxy-7α-methoxyconfertifolin ( | 296 | C16H24O5 | [ | |
| Polyketides | ||||
| Penicillic acid ( | 170 | C8H10O4 | Cultured | [ |
| - | - | Rhizospheric soil of | [ | |
| - | - | [ | ||
| 5(6)-Dihydropenicillic acid ( | 172 | C8H12O4 | Cultured | [ |
| - | - | Rhizospheric soil of | [ | |
| - | - | [ | ||
| Asperlactone ( | 184 | C9H12O4 | Environmental contamination sample, apple-packing house, Lleida, Spain | [ |
| Chlorohydroasperlactone A ( | 220 | C9H13ClO4 | Rhizospheric soil of | [ |
| Chlorohydroasperlactone B ( | 220 | C9H13ClO4 | Rhizospheric soil of | [ |
| - | - | [ | ||
| Aspilactonol B ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Aspilactonol E ( | 186 | C9H14O4 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochrin A ( | 202 | C9H14O5 | Rhizospheric soil of | [ |
| Asperochrin B ( | 184 | C9H12O4 | Rhizospheric soil of | [ |
| Asperochrin C ( | 184 | C9H12O4 | Rhizospheric soil of | [ |
| Asperochratide A ( | 216 | C10H16O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide B ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide C ( | 216 | C10H16O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide D ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide E( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide F ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide G ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide H ( | 188 | C9H16O4 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide I ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Asperochratide J ( | 216 | C10H16O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Aspyrone ( | 184 | C9H12O4 | Cultured | [ |
| - | - | Environmental contamination sample, apple-packing house, Lleida, Spain | [ | |
| - | - | [ | ||
| Chlorohydroaspyrone A ( | 220 | C9H13ClO4 | Rhizospheric soil of | [ |
| Chlorohydroaspyrone B ( | 220 | C9H13ClO4 | Rhizospheric soil of | [ |
| - | - | [ | ||
| Aspyronol ( | 216 | C10H16O5 | Rhizospheric soil of | [ |
| Dihydroaspyrone ( | 186 | C9H14O4 | Cultured | [ |
| - | - | Rhizospheric soil of | [ | |
| - | - | [ | ||
| - | - | [ | ||
| 8,9-Dihydroxy-8,9-deoxyaspyrone ( | 202 | C9H14O5 | Deep-sea water, Northeastern Pacific, China | [ |
| Ochraspergillic acid A ( | 307 | C15H17NO6 | [ | |
| Ochraspergillic acid B ( | 307 | C15H17NO6 | [ | |
| Aspinolide A ( | 184 | C10H16O3 | Cultured | [ |
| Aspinolide B ( | 284 | C14H20O6 | Cultured | [ |
| Aspinolide C ( | 282 | C14H18O6 | Cultured | [ |
| Aspinonene ( | 188 | C9H16O4 | Cultured | [ |
| 188 | C9H16O4 | Cultured | [ | |
| Quinone Derivatives | ||||
| Emodin ( | 270 | C15H10O5 | Moldy rice | [ |
| [ | ||||
| Xanthomegnin ( | 574 | C30H22O12 | Cultured | [ |
| - | - | [ | ||
| Viomellein ( | 560 | C30H24O11 | Cultured | [ |
| - | - | [ | ||
| Xanthine Derivatives | ||||
| Vioxanthin ( | 546 | C30H26O10 | Green coffee beans | [ |
| 274 | C15H14O5 | [ | ||
| Secalonic acid ( | 638 | C32H30O14 | Moldy rice | [ |
| Flavonoids | ||||
| Lucenin-2 ( | 610 | C27H30O16 | Marine sponge, Kanyakumari, peninsular land, southeast coast of Tamilnadu state, India | [ |
| Sterols | ||||
| 7-Nor-ergosterolide ( | 414 | C27H42O3 | [ | |
| 3β,11α-Dihydroxyergosta-8,24(28)-dien-7-one ( | 428 | C28H44O3 | [ | |
| 3β-Hydroxyergosta-8,24(28)-dien-7-one ( | 412 | C28H44O2 | [ | |
| (22 | 444 | C28H44O4 | [ | |
| (22 | 428 | C28H44O3 | [ | |
| Ergosterol ( | 396 | C28H44O | [ | |
| (22 | 392 | C28H40O | [ | |
| (22 | 430 | C28H46O3 | [ | |
| (22 | 444 | C29H48O3 | [ | |
| (22 | 414 | C28H46O2 | [ | |
| (22 | 428 | C28H44O3 | [ | |
| (22 | 428 | C28H44O3 | [ | |
| (22 | 446 | C28H46O4 | Deep-sea water, Northeastern Pacific, China | [ |
| Ochrasterone ( | 456 | C30H48O3 | Pacific Ocean, China | [ |
| Gymnasterone D ( | 406 | C28H38O2 | Marine Culture, Pacific Ocean, China | [ |
| Isocyathisterol ( | 410 | C28H42O2 | Marine Culture, Pacific Ocean, China | [ |
| Herbarulide ( | 424 | C28H40O3 | Marine Culture, Pacific Ocean, China | [ |
| Demethylincisterol A2 ( | 332 | C21H32O3 | Marine Culture, Pacific Ocean, China | [ |
| Other Metabolites | ||||
| 4-(3-Methyl-2- butenyl) oxy-1-phenyl acetic acid ( | 220 | C13H16O3 | Cultured | [ |
| Clavatol ( | 180 | C10H12O3 | [ | |
| 2,2-[bis-4-(2,3-Dihydroxypropoxy) phenyl]propane ( | 376 | C21H28O6 | Deep-sea water of the Northeastern Pacific, China | [ |
| 6-Ethyloct-3-yl-2- ethylhexyl ester ( | 418 | C26H42O4 | Marine sponge, Kanyakumari, peninsular land, southeast coast of Tamilnadu state, India | [ |
| Di-(2-Ethylhexyl) phthalate ( | 390 | C24H38O4 | Marine Culture, Pacific Ocean, China | [ |
| Campholene aldehyde ( | 152 | C10H16O | Marine sponge, Kanyakumari, peninsular, southeast coast of Tamilnadu state, India | [ |
| Dientriol ( | 172 | C9H16O3 | Cultured | [ |
| Triendiol ( | 154 | C9H14O2 | Cultured | [ |
| 2,10-Dimethyl 4-hydroxy-6-oxo-4-undecen-7-yne ( | 208 | C13H20O2 | Cultured | [ |
| Eythrol ( | 122 | C4H10O4 | Deep-sea water, Northeastern Pacific, China | [ |
| Galactomannan ( | 828 | C30H52O26 | [ |
Figure 3Pyrazine derivatives (25–38) reported from A. ochraceus.
Figure 4Diketopiperazines derivatives (39–51) reported from A. ochraceus.
Biological activity of reported metabolites from Aspergillus ochraceus.
| Compound Name | Biological Activity | Assay, Organism or Cell Line | Biological Results | Ref. | |
|---|---|---|---|---|---|
| Compound | Positive Control | ||||
| 3 | Anti HCV protease | SPA | 35.0 µM (IC50) | - | [ |
| Antioxidant | Spectrophotometry/DPPH | 25.0 µM (IC50) | [ | ||
| (3 | Antioxidant | Spectrophotometry/DPPH | 129.36 µM (IC50) | BHT 91.35 µM (IC50) | [ |
| Spectrophotometry/ABTS | 140.23 µM (IC50) | Trolox 101.23 µM (IC50) | [ | ||
| Spectrophotometry/FRAP | 11.96 µM (IC50) | Trolox 1.80 µM (IC50) | [ | ||
| ( | Antibacterial | Well diffusion/ | 64.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 32.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 8.0 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| ( | Antioxidant | Spectrophotometry/DPPH | 24.0 µM (IC50) | [ | |
| ( | Antioxidant | Spectrophotometry/DPPH | 62.90 µM (IC50) | BHT 91.35 µM (IC50) | [ |
| Spectrophotometry/ABTS | 70.92 µM (IC50) | Trolox 101.23 µM (IC50) | [ | ||
| Spectrophotometry/FRAP | 2.53 µM (IC50) | Trolox 1.80 µM (IC50) | [ | ||
| Ochratoxin B ( | Cytotoxicity | MTT/A2780 | 3.0 µM (IC50) | Cisplatin 2.2 µM (IC50) | [ |
| Flavacol ( | Inhibition of mitochondrial NADH oxidase | SMP/NADH oxidase | 34.6 µM (IC50) | - | [ |
| CJ-17,665 = Avrainvillamide ( | Antibacterial | Microdilution/ | 12.5 μg/mL (MIC) | Vancomycin 1.56 μg/mL (MIC) | [ |
| Microdilution/ | 12.5 μg/mL (MIC) | Vancomycin 0.39 μg/mL (MIC) | [ | ||
| Microdilution/ | 25.0 μg/mL (MIC) | Vancomycin 12.5 μg/mL (MIC) | [ | ||
| Cytotoxicity | MTT/HeLa | 1.1 μg/mL (IC90) | - | [ | |
| Stephacidin A ( | Cytotoxicity | MTT/PC-3 | 2.1 µM (IC50) | - | [ |
| MTT/LNCaP | 1.0 µM (IC50) | - | [ | ||
| MTT/A2780 | 4.0 µM (IC50) | - | [ | ||
| MTT/A2780/DDP | 6.8 µM (IC50) | - | [ | ||
| MTT/A2780/Tax | 3.6 µM (IC50) | - | [ | ||
| MTT/HCT-116 | 2.1 µM (IC50) | - | [ | ||
| MTT/HCT116/mdr+ | 6.7 µM (IC50) | - | [ | ||
| MTT/HCT116/topo | 13.1 µM (IC50) | - | [ | ||
| MTT/MCF-7 | 4.2 µM (IC50) | - | [ | ||
| MTT/SKBR3 | 2.15 µM (IC50) | - | [ | ||
| MTT/LX-1 | 4.22 µM (IC50) | - | [ | ||
| Inhibition of mitochondrial NADH Oxidase | SMP/NADH oxidase | 13.0 µM (IC50) | - | [ | |
| Anti-Parkinson’s disease | MPP+-induced SH-SY5Y cells | 2.45 µM (EC50) | Levodopa 2.06 µM (EC50) | [ | |
| Stephacidin B ( | Cytotoxicity | MTT/PC-3 | 0.37 µM (IC50) | - | [ |
| MTT/LNCaP | 0.06 µM (IC50) | - | [ | ||
| MTT/A2780 | 0.33 µM (IC50) | - | [ | ||
| MTT/A2780/DDP | 0.43 µM (IC50) | - | [ | ||
| MTT/A2780/Tax | 0.26 µM (IC50) | - | [ | ||
| MTT/HCT-116 | 0.46 µM (IC50) | - | [ | ||
| MTT/HCT116/mdr+ | 0.46 µM (IC50) | - | [ | ||
| MTT/HCT116/topo | 0.42 µM (IC50) | - | [ | ||
| MTT/MCF-7 | 0.27 µM (IC50) | - | [ | ||
| MTT/SKBR3 | 0.32 µM (IC50) | - | [ | ||
| MTT/LX-1 | 0.38 µM (IC50) | - | [ | ||
| Speramide A ( | Antibacterial | 2-Fold dilution/ | 0.8 µM (MIC) | - | [ |
| Notoamide B ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 5.31 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Notoamide C ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 7.39 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Notoamide F ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 2.98 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Notoamide I ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 2.30 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Versicolamide B ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 6.01 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Circumdatin A ( | Antioxidant | Spectrophotometry/DPPH | 32.0 µM (IC50) | [ | |
| 2-Hydroxycircumdatin C ( | Antioxidant | Spectrophotometry/DPPH | 9.9 µM (IC50) | BHT 88.2 µM (IC50) | [ |
| Cytotoxicity | CTG/U251 | 8.95 µM (IC50) | Adramycin 0.19 µM (IC50) | [ | |
| Circumdatin E ( | Inhibition of Mitochondrial NADH Oxidase | SMP/NADH oxidase | 2.5 µM (IC50) | - | [ |
| Circumdatin F ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 5.44 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Circumdatin G ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 7.39 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Circumdatin H ( | Inhibition of Mitochondrial NADH Oxidase | SMP/NADH oxidase | 1.5 µM (IC50) | - | [ |
| Circumdatin N ( | Anti-Parkinson’s disease | MPP+-induced SH-SY5Y cells | 10.77 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Ochrazepine A ( | Cytotoxicity | CTG/MV-4-11 | 3.94 µM (IC50) | Adramycin 0.16 µM (IC50) | [ |
| CTG/K562 | 6.05 µM (IC50) | Adramycin 0.02 µM (IC50) | [ | ||
| CTG/A673 | 3.10 µM (IC50) | Adramycin 0.13 µM (IC50) | [ | ||
| CTG/U87 | 8.67 µM (IC50) | Adramycin 0.12 µM (IC50) | [ | ||
| CTG/A549 | 9.62 µM (IC50) | Adramycin 0.10 µM (IC50) | [ | ||
| CTG/N87 | 6.10 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/H1299 | 7.14 µM (IC50) | Adramycin 0.49 µM (IC50) | [ | ||
| CTG/HUCCT1 | 11.32 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/B16F10 | 11.22 µM (IC50) | Adramycin 0.02 µM (IC50) | [ | ||
| CTG/Karpass299 | 5.89 µM (IC50) | Adramycin 0.39 µM (IC50) | [ | ||
| CTG/HEK-293F | 12.91 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/L02 | 27.42 µM (IC50) | Adramycin 0.10 µM (IC50) | [ | ||
| Ochrazepine B ( | Cytotoxicity | CTG/U251 | 9.91 µM (IC50) | Adramycin 0.19 µM (IC50) | [ |
| CTG/HEK-293F | 73.96 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| Ochrazepine C ( | Cytotoxicity | CTG/A673 | 8.24 µM (IC50) | Adramycin 0.13 µM (IC50) | [ |
| CTG/U87 | 9.04 µM (IC50) | Adramycin 0.12 µM (IC50) | [ | ||
| CTG/HepB3 | 10.28 µM (IC50) | Adramycin 17.58 µM (IC50) | [ | ||
| CTG/HEK-293F | 73.03 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| Ochrazepine D ( | Cytotoxicity | CTG/U251 | 8.26 µM (IC50) | Adramycin 0.19 µM (IC50) | [ |
| CTG/HEK-293F | 54.58 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| Perlolyrine ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 9.97 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Ochracesol A ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 17.84 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| 6β,9α-Dihydroxy-14- | Cytotoxicity | CCK-8/H1975 | 2.08 µM (IC50) | Trichostatin A 0.09 µM (IC50) | [ |
| CCK-8/U937 | 1.95 µM (IC50) | Trichostatin A 0.05 µM (IC50) | [ | ||
| CCK-8/K562 | 4.33 µM (IC50) | Trichostatin A 0.16 µM (IC50) | [ | ||
| CCK-8/BGC823 | 2.32 µM (IC50) | Trichostatin A 0.08 µM (IC50) | [ | ||
| CCK-8/Molt-4 | 2.39 µM (IC50) | Trichostatin A 0.03 µM (IC50) | [ | ||
| CCK-8/MCF-7 | 4.25 µM (IC50) | Trichostatin A 0.06 µM (IC50) | [ | ||
| CCK-8/A549 | 2.41 µM (IC50) | Trichostatin A 0.05 µM (IC50) | [ | ||
| CCK-8/HeLa | 6.12 µM (IC50) | Trichostatin A 0.10 µM (IC50) | [ | ||
| CCK-8/HL-60 | 2.44 µM (IC50) | Trichostatin A 0.03 µM (IC50) | [ | ||
| CCK-8/Huh-7 | 3.28 µM (IC50) | Trichostatin A 0.09 µM (IC50) | [ | ||
| CCK-8/ACHN | 11.0 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ | ||
| CCK-8/OS-RC-2 | 8.2 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 4.3 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| Antiviral | CCK-8/H3N2 | 17.0 µM (IC50) | Oseltamivir A 0.008 µM (IC50) | [ | |
| CCK-8/EV71 | 9.4 µM (IC50) | Oseltamivir A 0.06 µM (IC50) | [ | ||
| Insulicolide A ( | Cytotoxicity | CCK-8/H1975 | 4.63 µM (IC50) | Trichostatin A 0.09 µM (IC50) | [ |
| CCK-8/U937 | 3.97 µM (IC50) | Trichostatin A 0.05 µM (IC50) | [ | ||
| CCK-8/K562 | 4.76 µM (IC50) | Trichostatin A 0.16 µM (IC50) | [ | ||
| CCK-8/BGC823 | 2.78 µM (IC50) | Trichostatin A 0.08 µM (IC50) | [ | ||
| CCK-8/Molt-4 | 2.11 µM (IC50) | Trichostatin A 0.03 µM (IC50) | [ | ||
| CCK-8/MCF-7 | 6.08 µM (IC50) | Trichostatin A 0.06 µM (IC50) | [ | ||
| CCK-8/A549 | 2.86 µM (IC50) | Trichostatin A 0.05 µM (IC50) | [ | ||
| CCK-8/HeLa | 6.35 µM (IC50) | Trichostatin A 0.10 µM (IC50) | [ | ||
| CCK-8/HL-60 | 2.34 µM (IC50) | Trichostatin A 0.03 µM (IC50) | [ | ||
| CCK-8/Huh-7 | 2.35 µM (IC50) | Trichostatin A 0.09 µM (IC50) | [ | ||
| CCK-8/ACHN | 1.5 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ | ||
| CCK-8/OS-RC-2 | 1.5 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 0.89 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| 14-O-Acetylinsulicolide A ( | Cytotoxicity | CCK-8/ACHN | 4.1 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ |
| CCK-8/OS-RC-2 | 5.3 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 2.3 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| 9-Deoxyinsulicolide A ( | Cytotoxicity | CCK-8/ACHN | 25.0 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ |
| CCK-8/OS-RC-2 | 30.0 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 20.0 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| Insulicolide B ( | Cytotoxicity | CCK-8/ACHN | 30.0 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ |
| CCK-8/OS-RC-2 | 23.0 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 24.0 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| Insulicolide C ( | Cytotoxicity | CCK-8/ACHN | 13.0 µM (IC50) | Sorafenib 3.4 µM (IC50) | [ |
| CCK-8/OS-RC-2 | 11.0 µM (IC50) | Sorafenib 7.0 µM (IC50) | [ | ||
| CCK-8/786-O | 14.0 µM (IC50) | Sorafenib 4.9 µM (IC50) | [ | ||
| Penicillic acid ( | Antibacterial | Well diffusion/ | 1.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 32.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 0.5 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| Chlorohydroasperlactone A ( | Antibacterial | Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| Asperochrin A ( | Antibacterial | Well diffusion/ | 8.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 8.0 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| Aspyrone ( | Cytotoxicity | CTG/MV-4-11 | 2.54 µM (IC50) | Adramycin 0.16 µM (IC50) | [ |
| CTG/K562 | 5.22 µM (IC50) | Adramycin 0.02 µM (IC50) | [ | ||
| CTG/A673 | 8.55 µM (IC50) | Adramycin 0.13 µM (IC50) | [ | ||
| CTG/N87 | 4.57 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/H1299 | 5.83 µM (IC50) | Adramycin 0.49 µM (IC50) | [ | ||
| CTG/HUCCT1 | 9.79 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/B16F10 | 5.89 µM (IC50) | Adramycin 0.02 µM (IC50) | [ | ||
| CTG/Karpass299 | 2.57 µM (IC50) | Adramycin 0.39 µM (IC50) | [ | ||
| CTG/HepB3 | 5.48 µM (IC50) | Adramycin 17.58 µM (IC50) | [ | ||
| CTG/HA431 | 5.92 µM (IC50) | Adramycin 0.17 µM (IC50) | [ | ||
| CTG/143B | 6.32 µM (IC50) | Adramycin 0.10 µM (IC50) | [ | ||
| CTG/MKN-45 | 5.79 µM (IC50) | Adramycin 0.20 µM (IC50) | [ | ||
| CTG/H1975 | 2.99 µM (IC50) | Adramycin 0.09 µM (IC50) | [ | ||
| CTG/Hl-60 | 6.89 µM (IC50) | Adramycin 0.21 µM (IC50) | [ | ||
| CTG/DU145 | 5.61 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/SPC-A1 | 9.51 µM (IC50) | Adramycin 0.19 µM (IC50) | [ | ||
| CTG/HEK-293F | 50.35 µM (IC50) | Adramycin 0.05 µM (IC50) | [ | ||
| CTG/L02 | 14.20 µM (IC50) | Adramycin 0.10 µM (IC50) | [ | ||
| Chlorohydroaspyrone A ( | Antibacterial | Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 32.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| Chlorohydroaspyrone B ( | Antibacterial | Well diffusion/ | 16.0 μg/mL (MIC) | Chloramphenicol 4.0 μg/mL (MIC) | [ |
| Well diffusion/ | 32.0 μg/mL (MIC) | Chloramphenicol 1.0 μg/mL (MIC) | [ | ||
| Well diffusion/ | 32.0 μg/mL (MIC) | Chloramphenicol 8.0 μg/mL (MIC) | [ | ||
| Viomellein ( | Cytotoxicity | MTT/L5178Y | 5.3 µM (IC50) | Kahalalide F 4.3 µM (IC50) | [ |
| MTT/A2780 | 5.0 µM (IC50) | Cisplatin 2.2 µM (IC50) | [ | ||
| (22 | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 35.71 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Ochrasterone ( | Antioxidant | DPPH | 189.10 µM (IC50) | BHT 91.35 µM (IC50) | [ |
| ABTS | 60.21 µM (IC50) | Trolox 101.23 µM (IC50) | [ | ||
| FRAP | 57.20 µM (IC50) | Trolox 1.80 µM (IC50) | [ | ||
| Gymnasterone D ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 38.75 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Isocyathisterol ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 46.18 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Herbarulide ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 37.67 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Demethylincisterol A2 ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 49.53 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
| Clavatol ( | Antioxidant | DPPH | 30.0 µM (IC50) | [ | |
| Di-(2-ethylhexyl) phthalate ( | Anti-Parkinson’s disease | MPP+--induced SH-SY5Y cells | 80.21 µM (EC50) | Levodopa 2.06 µM (EC50) | [ |
Scheme 1Biosynthesis pathway of speramide A (46) from (+)-stephacidin A (44) via oxidation and rearrangement [23].
Figure 5Diketopiperazines derivatives (52–62) reported from A. ochraceus.
Figure 6Benzodiazepine derivatives (63–72) reported from A. ochraceus.
Figure 7Benzodiazepine derivatives (73–79) reported from A. ochraceus.
Scheme 2Semisynthetic and biosynthetic pathways of ochrazepines A–D (76–79) [31].
Figure 8Indole and other alkaloids (80–87) reported from A. ochraceus.
Figure 9Peptides (88–89) and sesquiterpenoids (90–96) reported from A. ochraceus.
Figure 10Polyketides (97–112) reported from A. ochraceus.
Figure 11Polyketides (113–129) reported from A. ochraceus.
Scheme 3Biosynthesis pathway of aspinonene (128) [100]. PKS: Polyketide synthase; MO: monooxygenase; Path A: 1,2-addition + allylic rearrangement; Path B: 1,4-addition.
Figure 12Quinone (130–132) and xanthine (133–136) derivatives and flavonoids (135) reported from A. ochraceus.
Figure 13Sterols (137–144) reported from A. ochraceus.
Figure 14Sterols (145–154) reported from A. ochraceus.
Figure 15Other metabolites (155–165) reported from A. ochraceus.
Figure 16Different metabolites reported from A. ochraceus. ISC: Isocoumarins; PYZ: pyrazines; DKP: diketopiperazines; BDZ: benzodiazepine: IOA: indole and other alkaloids; PEP: peptides; SESQ: sesquiterpenoids; PKs: polyketides; QU: quinones; XT: xanthes; FLAV: flavonoids; ST: sterols; OM: other metabolites.
Figure 17Number of metabolites reported from A. ochraceus isolated from various sources.